Table 1. Selected exposures and characteristics with unadjusted ORs and 95% CIs for CMV seropositive women according to the development of new antibody specificity against CMV epitopes (CMV reinfection).
| Variables | CMV Reinfection (n=59), n% |
No CMV Reinfection (n=146), n% |
Unadjusted OR (95% CI) |
|---|---|---|---|
| White Race | 10 (16.9) | 9 (6.2) | 3.11 (1.05-9.15) |
| Maternal age < 19 years | 42 (71.2) | 103 (70.6) | 1.03 (0.51-2.15) |
| Sexual partners > 1 | 57 (96.6) | 143 (98.6) a | 0.39 (0.03-5.65) |
| STIs > 1 | 13 (22.0) | 31 (21.2) | 1.05 (0.46-2.28) |
| Bacterial Vaginosis | 6 (10.2) | 24 (16.4) | 0.58 (0.18-1.56) |
| Chlamydia | 3 (5.1) | 6 (4.1) | 1.25 (0.20-6.09) |
| Herpes Simples Virus | 1 (1.7) | 3 (2.1) | 0.82 (0.01-10.49) |
| Trichomoniasis | 3 (5.1) | 3 (2.1) | 2.55 (0.33-19.54) |
| Syphilis | 0 (0) | 0 (0) | --- |
| Gonorrhea | 0 (0) | 4 (2.7) | 0 (0-2.75) |
| Direct care of children | 41 (69.5) | 95 (65.1) | 1.22 (0.61-2.50) |
| More than 2 Children <6y of age living in the household | 16 (27.1) | 34 (23.3) | 1.23 (0.57-2.56) |
a
Data available for 145 subjects